| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9a6175f943b1fe5271a07d4e3447e596
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42f18181c4736a88bc8a64381af1ec69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3b3177abb82e4b3b28e8687247542857
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_756f9d0420cd4791e9e3572a94452d89
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a215e6e8bbc4a023db2ea261a3e7249b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9e54ffb7f81cc1aa256dc2f79e3ca70f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_239b1fe8a19ef004b8c47c090a9c16d5 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6869
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6872 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-566
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-64 |
| filingDate |
2011-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c266eb3d78df758279d75fe1ace0b371
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9735b58c5f5046272598bdbfa6bbe4cd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a3b122c02458860df50f795776ecb46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a65503eff5b09d1dcbf7c76a088c023
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04f59ff293db847fc8af1e2b6c4dd6c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a87e7f253c7916185ae8ceaba9a85b91 |
| publicationDate |
2012-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2012021432-A1 |
| titleOfInvention |
Phosphorylated NF45 Biomarkers, Antibodies And Methods Of Using Same |
| abstract |
The present invention relates to isolated phosphorylated NF45 peptides and isolated phosphorylation site-specific antibody or antigen-binding portion thereof that specifically binds a phosphorylated NF45 protein. The present invention also relates to methods of utilizing these antibodies to determine the therapeutic efficacy of a candidate compound and methods for screening for candidate compounds that increase the phosphorylation of NF45 protein in a cell. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9561266-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10682399-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11414458-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013177593-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10640535-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013177593-A2 |
| priorityDate |
2010-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |